Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

This study has been withdrawn prior to enrollment.
(Sub-Investigator reloacted to another institution)
Sponsor:
Information provided by (Responsible Party):
Pamela New, MD, The Methodist Hospital System
ClinicalTrials.gov Identifier:
NCT00109798
First received: May 3, 2005
Last updated: November 20, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: July 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)